Ginseng RNA new drug techniques and Probiotics RNA new drug technique

Chair Prof. Jiang Zhi Hong’s Research Team-Ginseng RNA new drug techniques and Probiotics RNA new drug technique

Two Ginseng RNA new drug techniques, developed by the research team of Chair Prof. Zhihong Jiang, Vice President of Macau University of Science and Technology and Director of the State Key Laboratory of Quality Research in Chinese Medicine, represent respectively a combo of therapeutics and drugs for preventing or treating heart diseases, and a combo of therapeutics and drugs containing non-coding RNA molecules and antibody targeting tumor antigen for preventing and/or treating cancer. The Probiotics RNA new drug technique represents a combo of therapeutics and drugs containing double-stranded RNA molecules for treating colorectal cancer. MACAU TAK SENG BIOLOGICAL TECHNOLOGY LIMITED gained the IP of the above projects at a price of RMB 150 million and 2% products sales.

The above figure represents the molecular diagram of a novel RNA drug derived from ginseng; The below figure depicts the analysis of the drug molecule conducted by researchers.